Ranibizumab Holds Visual Line in Real-World Study

by Medscape • 2014/04/16 • 0 Comments

A postmarketing study shows that previously treated and treatment-naïve patients had good visual acuity results at 1 year, with a low incidence of adverse ocular events.
Medscape Medical News

← Ophthalmologist also liable for hospital’s false claims

Dietary actinidin from kiwifruit (Actinidia deliciosa cv. Hayward) increases gastric digestion and the gastric emptying rate of several dietary proteins in growing rats →

Post navigation